• Ronald L Burke, Kelly G Vest, Angelia A Eick, Jose L Sanchez, Matthew C Johns, Julie A Pavlin, Richard G Jarman, Jerry L Mothershead, Miguel Quintana, Thomas Palys, Michael J Cooper, Jian Guan, David Schnabel, John Waitumbi, Alisa Wilma, Candelaria Daniels, Matthew L Brown, Steven Tobias, Matthew R Kasper, Maya Williams, Jeffrey A Tjaden, Buhari Oyofo, Timothy Styles, Patrick J Blair, Anthony Hawksworth, Joel M Montgomery, Hugo Razuri, Alberto Laguna-Torres, Randal J Schoepp, David A Norwood, Victor H Macintosh, Thomas Gibbons, Gregory C Gray, David L Blazes, Kevin L Russell, AFHSC-GEIS Influenza Surveillance Writing Group, Jennifer Rubenstein, Kyle Hathaway, Robert Gibbons, In-Kyu Yoon, David Saunders, Jariyanart Gaywee, Mikal Stoner, Ans Timmermans, Sanjaya K Shrestha, Velasco John Mark S JM, Maria T Alera, Darunee Tannitisupawong, Khin Saw Myint, Sathit Pichyangkul, Ben Woods, Kurt H Jerke, Michael G Koenig, Denis K Byarugaba, Fred Wabwire Mangen, Berhane Assefa, Gary Brice, Moustafa Mansour, Guillermo Pimentel, Peter Sebeny, Maha Talaat, Tamer Saeed, Ben Espinosa, Dennis Faix, Ryan Maves, Tadeusz Kochel, James Smith, Alicia Guerrero, Gen Maupin, Paul Sjoberg, Mark Duffy, Jason Garner, Linda Canas, Elizabeth Macias, Robert A Kuschner, Dennis Shanks, Sheri Lewis, Gosia Nowak, Lucy M Ndip, Nathan Wolfe, and Karen Saylors.
• Armed Forces Health Surveillance Center, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA. Ronald.L.Burke@us.army.mil
• Bmc Public Health. 2011 Mar 4; 11 Suppl 2: S6.

AbstractThe Armed Forces Health Surveillance Center's Division of Global Emerging Infections Surveillance and Response System (AFHSC-GEIS) supports and oversees surveillance for emerging infectious diseases, including respiratory diseases, of importance to the U.S. Department of Defense (DoD). AFHSC-GEIS accomplishes this mission by providing funding and oversight to a global network of partners for respiratory disease surveillance. This report details the system's surveillance activities during 2009, with a focus on efforts in responding to the novel H1N1 Influenza A (A/H1N1) pandemic and contributions to global public health. Active surveillance networks established by AFHSC-GEIS partners resulted in the initial detection of novel A/H1N1 influenza in the U.S. and several other countries, and viruses isolated from these activities were used as seed strains for the 2009 pandemic influenza vaccine. Partners also provided diagnostic laboratory training and capacity building to host nations to assist with the novel A/H1N1 pandemic global response, adapted a Food and Drug Administration-approved assay for use on a ruggedized polymerase chain reaction platform for diagnosing novel A/H1N1 in remote settings, and provided estimates of seasonal vaccine effectiveness against novel A/H1N1 illness. Regular reporting of the system's worldwide surveillance findings to the global public health community enabled leaders to make informed decisions on disease mitigation measures and controls for the 2009 A/H1N1 influenza pandemic. AFHSC-GEIS's support of a global network contributes to DoD's force health protection, while supporting global public health.

17 keywords...

hide…